# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Fanconi Anemia
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Fanconi Anemia**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** cyberian
**Generated:** 2026-02-08T10:19:52.670309

1. alpi-2015-ube2t-deficiency-fulltext.html
2. alpi-2015-ube2t-deficiency-fulltext.md
3. alpi-2015-ube2t-deficiency-summary.md
4. fang-2025-fanconi-review-fulltext.html
5. fang-2025-fanconi-review-fulltext.md
6. fang-2025-fanconi-review-fulltext.txt
7. fang-2025-fanconi-review-paper.pdf
8. fang-2025-fanconi-review-summary.md
9. garaycoechea-2018-aldehydes-hsc-fulltext.html
10. garaycoechea-2018-aldehydes-hsc-fulltext.md
11. garaycoechea-2018-aldehydes-hsc-summary.md
12. joo-2011-id2-structure-fulltext.html
13. joo-2011-id2-structure-fulltext.md
14. joo-2011-id2-structure-summary.md
15. kim-2012-genesdev-icls-fulltext.html
16. kim-2012-genesdev-icls-fulltext.md
17. kim-2012-genesdev-icls-summary.md
18. kottemann-2013-slx4-fulltext.html
19. kottemann-2013-slx4-fulltext.md
20. kottemann-2013-slx4-summary.md
21. machida-2007-ube2t-chromatin-fulltext.html
22. machida-2007-ube2t-chromatin-fulltext.md
23. machida-2007-ube2t-chromatin-summary.md
24. mackay-2010-fanconi-expanded-fulltext.html
25. mackay-2010-fanconi-expanded-fulltext.md
26. mackay-2010-fanconi-expanded-summary.md
27. mackay-2013-fan1-nuclease-fulltext.html
28. mackay-2013-fan1-nuclease-fulltext.md
29. mackay-2013-fan1-nuclease-summary.md
30. rajan-2016-id2-recruitment-fulltext.html
31. rajan-2016-id2-recruitment-fulltext.md
32. rajan-2016-id2-recruitment-summary.md
33. yamamoto-2011-slx4-icls-fulltext.html
34. yamamoto-2011-slx4-icls-fulltext.md
35. yamamoto-2011-slx4-icls-summary.md